Today: 13 May 2026
Nebius Stock Jumps After $643 Million Eigen AI Deal — What Investors Need To Know
4 May 2026
2 mins read

Nebius Stock Jumps After $643 Million Eigen AI Deal — What Investors Need To Know

Amsterdam, May 4, 2026, 14:04 CEST

Nebius Group N.V. jumped back into the spotlight Monday, as the Amsterdam AI cloud outfit struck a deal to acquire Eigen AI, the U.S. inference and model optimization startup, for roughly $643 million in cash and stock.

Nebius is set to gain greater software control over inference—the process where a trained AI model generates responses—just as investors question if the rapid expansion of AI cloud companies will translate costly chip and data center investments into steady income. According to a May 1 SEC filing, the deal involves MagicByte Inc., which operates as Eigen AI Labs, and doesn’t require approval from Nebius shareholders.

Nebius shares finished Friday at $154.49, up 11.76%. U.S. premarket data on Monday pointed to more gains. Investors are already kicking the tires on the acquisition, with first-quarter results due May 13—so scrutiny comes early, not months down the line.

The company plans to integrate Eigen AI’s tech into its Nebius Token Factory managed inference platform. Eigen’s founders will set up a Nebius engineering and research hub in the Bay Area. Eigen focuses on boosting production AI model speed and cost efficiency—areas where even minor gains in computing power can add up at scale.

The filing laid out the specifics: as much as $98 million in cash, plus around 3.8 million Nebius Class A shares, depending on the terms. Founders and those staying on get just 15% of their share allotment up front—everything else vests over four years. Most of the payout is locked up, designed to keep employees from jumping ship.

Roman Chernin, co-founder and chief business officer at Nebius, pointed to a need for “optimized inference and infrastructure scale” for AI builders. Eigen AI’s co-founder and CEO Ryan Hanrui Wang said the goal is to allow developers to “run models reliably in production” and not worry about the infrastructure underneath.

With this purchase, Nebius steps right into the thick of the AI compute battle, looking to carve out an identity apart from heavyweight CoreWeave and niche cloud players. The company is betting on a mix of Nvidia-backed infrastructure and a bigger dose of its proprietary software stack. Reuters has tagged Nebius as a leading “neocloud” company—those renting out hardware and cloud muscle to other tech firms focused on AI workloads. Reuters

There’s not much room on the calendar. CoreWeave plans to release first-quarter numbers on May 7, which will hand investors an early look at how demand, margins, and costs are shaping up for AI infrastructure players. Nebius lands six days after that.

Nebius has been pressing bigger clients and suppliers to help bankroll its growth. Back in March, the company unveiled a five-year AI infrastructure deal with Meta that could total around $27 billion: $12 billion locked in for dedicated capacity, plus an option for Meta to buy more compute if needed.

Earlier in March, Nvidia agreed to put $2 billion into Nebius and back an ambitious project: more than 5 gigawatts of Nvidia systems to be rolled out by 2030. The chipmaker’s investment followed Nebius locking in a multi-year infrastructure deal with Microsoft, which centers on reserved capacity from a Vineland, New Jersey data center.

Still, the deal isn’t done yet, and the risks are out in the open. According to the SEC filing, closing hinges on standard conditions—like antitrust sign-off. The company added in its own release that factors like pulling off the integration, holding on to clients, and securing funding could all weigh on its performance. None of that is trivial for a business pushing to expand data center capacity as AI infrastructure costs stay elevated.

Right now, investors see Eigen AI as just an extra layer on top of a broader infrastructure push. The focus shifts next to Nebius: when it reports on May 13, the real question is whether its spending matches up with actual demand—more important than any deal headline this time.

Stock Market Today

  • Global Medical Response Goes Public with $479 Million IPO on NYSE
    May 13, 2026, 9:25 AM EDT. Global Medical Response (NYSE: GMRS) debuted on the New York Stock Exchange after completing a $479 million initial public offering (IPO). CEO Nick Loporcaro discussed the company's next steps during the NYSE Live segment. The IPO marks a significant milestone for GMRS as it enters public markets. Equities showed strength early in the session, boosted by the U.S. April Producer Price Index (PPI) report. Meanwhile, Sea Limited shares surged over 13% following a 38% revenue growth report. Rollins (NYSE: ROL) prepares to showcase its growth strategy at its 2026 Investor and Analyst Conference. Investors are watching IPO activity closely amid broader market resilience.

Latest articles

Crypto ATM Crackdown Spreads as $389 Million Scam Losses Put Kiosks in Crosshairs

Crypto ATM Crackdown Spreads as $389 Million Scam Losses Put Kiosks in Crosshairs

13 May 2026
Spokane Valley has ordered all virtual-currency kiosks removed within 30 days after police linked them to fraud and one suicide. The FBI reported $389 million in losses tied to crypto ATMs in 2025, with older adults suffering most. Minnesota banned the machines statewide this month. Industry groups argue such bans hurt legitimate users and dispute fraud allegations.
Hot PPI Shock Hits Wall Street As Oil Inventory Test Looms

Hot PPI Shock Hits Wall Street As Oil Inventory Test Looms

13 May 2026
U.S. producer prices rose 1.4% in April, the largest monthly gain since March 2022, with the Producer Price Index up 6.0% year-over-year, the Bureau of Labor Statistics said Wednesday. Energy prices surged 7.8%, gasoline 15.6%. S&P 500 futures turned negative after the data. The American Petroleum Institute reported U.S. crude inventories fell by 2.2 million barrels last week.

Popular

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read

12 May 2026
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64.
Palantir Stock Faces 9% Earnings Move As AI Pricing Power Goes On Trial
Previous Story

Palantir Stock Faces 9% Earnings Move As AI Pricing Power Goes On Trial

BlackBerry Stock Jumps As QNX Software Puts Its Old Phone Name Back On Wall Street’s Radar
Next Story

BlackBerry Stock Jumps As QNX Software Puts Its Old Phone Name Back On Wall Street’s Radar

Go toTop